1. Home
  2. EOLS vs GHM Comparison

EOLS vs GHM Comparison

Compare EOLS & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • GHM
  • Stock Information
  • Founded
  • EOLS 2012
  • GHM 1936
  • Country
  • EOLS United States
  • GHM United States
  • Employees
  • EOLS N/A
  • GHM N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • GHM Industrial Machinery/Components
  • Sector
  • EOLS Health Care
  • GHM Industrials
  • Exchange
  • EOLS Nasdaq
  • GHM Nasdaq
  • Market Cap
  • EOLS 493.5M
  • GHM 577.9M
  • IPO Year
  • EOLS 2018
  • GHM N/A
  • Fundamental
  • Price
  • EOLS $7.66
  • GHM $47.72
  • Analyst Decision
  • EOLS Strong Buy
  • GHM Strong Buy
  • Analyst Count
  • EOLS 5
  • GHM 2
  • Target Price
  • EOLS $21.25
  • GHM $60.00
  • AVG Volume (30 Days)
  • EOLS 1.2M
  • GHM 89.0K
  • Earning Date
  • EOLS 11-05-2025
  • GHM 11-07-2025
  • Dividend Yield
  • EOLS N/A
  • GHM N/A
  • EPS Growth
  • EOLS N/A
  • GHM 184.08
  • EPS
  • EOLS N/A
  • GHM 1.26
  • Revenue
  • EOLS $277,941,000.00
  • GHM $215,432,000.00
  • Revenue This Year
  • EOLS $14.01
  • GHM $10.98
  • Revenue Next Year
  • EOLS $29.46
  • GHM $10.59
  • P/E Ratio
  • EOLS N/A
  • GHM $37.94
  • Revenue Growth
  • EOLS 17.15
  • GHM 14.64
  • 52 Week Low
  • EOLS $5.71
  • GHM $24.78
  • 52 Week High
  • EOLS $17.82
  • GHM $58.00
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 50.21
  • GHM 43.60
  • Support Level
  • EOLS $7.19
  • GHM $46.88
  • Resistance Level
  • EOLS $7.67
  • GHM $51.00
  • Average True Range (ATR)
  • EOLS 0.34
  • GHM 1.81
  • MACD
  • EOLS 0.13
  • GHM -0.15
  • Stochastic Oscillator
  • EOLS 79.29
  • GHM 19.31

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About GHM Graham Corporation

Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.

Share on Social Networks: